Inaba Hidefumi, Martin William, De Groot Anne S, Qin Shuwen, De Groot Leslie J
Brown University/Medicine/Endocrinology, Box G, Room E-308, 70 Ship Street, Providence, Rhode Island 02903, USA.
J Clin Endocrinol Metab. 2006 Jun;91(6):2286-94. doi: 10.1210/jc.2005-2537. Epub 2006 Apr 4.
Graves' disease (GD) is characterized by autoimmunity to the TSH receptor (TSHR).
We sought to identify T cell epitopes in TSHR that initiate this immune response and their interaction with human histocompatibility leukocyte antigen (HLA) molecules predisposing to GD.
We examined the affinity of 31 overlapping peptides spanning the TSHR extracellular domain for binding in vitro to five purified HLA-DR molecules; DRB10101 (DR1), DRB11501 (DR2), DRB10301 (DR3), DRB11101 (DR5), and DRB1*0701 (DR7). We scanned the TSHR extracellular domain using a T cell epitope-mapping algorithm, EpiMatrix. We compared these results with clinical studies of GD patients measuring in vitro T cell responses to the peptides.
The study was conducted at a university laboratory.
Patients included 200 serial adult clinic patients with GD.
There were no interventions.
Binding affinity of epitopes, predicted affinity, and reported T cell stimulation data were measured.
Most peptides bound with intermediate or high affinity to one or more HLA-DR molecule. Peptides binding to HLA-DR3 and HLA-DR5, which predispose to GD, exhibited moderate binding affinities overall, whereas most peptides binding to GD-protective HLA-DR7 bound with high affinity. These differences may relate to T cell selection in the thymus. Binding affinity of peptides correlated strongly with EpiMatrix-predicted affinity for HLA-DRB10101, DRB11501, DR3, and DRB1*0701 but not HLA-DR5. Average IC(50) values correlated significantly with clinical T cell stimulation data.
Three different methods for identifying immunogenic peptides did not provide a uniform picture of important TSHR epitopes. However, peptide 132-150 (GIFNTGLKMFPDLTKVYST) was identified by three methods as an important epitope in GD; the possible importance of peptides 145-163, 158-176, 207-222, 248-263, 272-291, and 343-362 was also identified.
格雷夫斯病(GD)的特征是针对促甲状腺激素受体(TSHR)的自身免疫反应。
我们试图确定TSHR中引发这种免疫反应的T细胞表位,以及它们与易患GD的人类组织相容性白细胞抗原(HLA)分子之间的相互作用。
我们检测了31个覆盖TSHR细胞外结构域的重叠肽段在体外与5种纯化的HLA-DR分子的结合亲和力;DRB10101(DR1)、DRB11501(DR2)、DRB10301(DR3)、DRB11101(DR5)和DRB1*0701(DR7)。我们使用T细胞表位映射算法EpiMatrix扫描TSHR细胞外结构域。我们将这些结果与测量GD患者体外T细胞对这些肽段反应的临床研究结果进行了比较。
该研究在一所大学实验室进行。
患者包括200例连续的成年门诊GD患者。
无干预措施。
测量表位的结合亲和力、预测亲和力以及报告的T细胞刺激数据。
大多数肽段与一种或多种HLA-DR分子以中等或高亲和力结合。与易患GD的HLA-DR3和HLA-DR5结合的肽段总体表现出中等结合亲和力,而大多数与具有GD保护作用的HLA-DR7结合的肽段以高亲和力结合。这些差异可能与胸腺中的T细胞选择有关。肽段的结合亲和力与EpiMatrix预测的对HLA-DRB10101、DRB11501、DR3和DRB1*0701的亲和力密切相关,但与HLA-DR5无关。平均IC50值与临床T细胞刺激数据显著相关。
三种不同的鉴定免疫原性肽段的方法并未对重要的TSHR表位给出统一的结果。然而,肽段132-150(GIFNTGLKMFPDLTKVYST)被三种方法鉴定为GD中的一个重要表位;肽段145-163、158-176、207-222、248-263、272-291和3乐动・LDSports(中国)官方网站43-362的潜在重要性也被确定。